AllTest Biotech Showcases Comprehensive Rapid and Immunoassay Diagnostics at MEDICA 2025

Hangzhou AllTest Biotech is showcasing its rapid diagnostic kits and immunoassay platforms at MEDICA 2025. At Booth G11 in Hall 1, the company’s exhibit highlights a wide array of pioneering products across key categories.

AllTest’s comprehensive test lines feature state-of-the-art technologies, such lateral flow immunoassays with portable reader options, fluorescence immunoassay devices, dry biochemistry analyzers, and chemiluminescence immunoassay systems.

Image: AllTest is exhibiting a a wide array of innovative products across key categories at MEDICA 2025 (Photo courtesy of AllTest)

Newly launched items include a multiplex respiratory antigen rapid test for swift respiratory pathogen detection, a streamlined Drink Check Test, and a one‑step HIV 1.2 Rapid Test that delivers results in 15 minutes. The lineup also introduces tools for stomach health assessment and viral diarrhea diagnosis.

Established products on display include the hCG Pregnancy Rapid Test (compatible with visual and digital reading); the all‑in‑one Home Use Test Series covering UTI, ovulation, and pregnancy; the HBsAg Rapid Test; and an FDA‑approved Multi‑Drug 2–20 Drugs Rapid Test.

Attendees can review how the platforms align with laboratory and point‑of‑care workflows, from rapid antigen screening to automated immunoassay processing. The company’s experts will be available to show how the company's solutions boost diagnostic speed and transform patient care.

Related Links:
Hangzhou AllTest Biotech